Immunex Corp said it received Food andDrug Administration approval to begin human clinical testing ofa protein as a possible treatment for cancer.    The company said the protein, granulocyte-macrophage colonystimulating factor, stimulates production of white blood cellsessential to the body's immune function. It said it isdeveloping the compound with &lt;Behringwerke AG>, a subsidiary ofHoechst AG.    Immunex said the drug's potential applications includerestoration of white blood cell function, destruction of tumorcells, and as an AIDS treatment. Reuter&#3;